Impaired phasic insulin and amylin secretion in diabetic rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 3 38-3, 1998, Pages

  Leahy, Jack L ^a   Fineman, Mark S ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Experimental models; Pancreas hormone content; Pancreas perfusion; Partially pancreatectomized rats; Radioimmunoassay; Type 2 diabetes

Indexed keywords

AMYLIN; ARGININE; GLUCOSE; INSULIN; TOLBUTAMIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SECRETION;

EID: 0031668006     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.3.e457     Document Type: Article

References (38)

1. Albano, J. D. M., R. P. Ekins, G. Maritz, and R. C. Turner. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol. 70: 487-509, 1972.
2. Bonner-Weir, S., S. Deery, and G. C. Weir. Growth of regenerating islet tissue is enhanced by VMH lesions (Abstract). Diabetes 35, Suppl.1: 97A, 1986.
3. Bonner-Weir, S., D. F. Trent, and G. C. Weir. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J. Clin. Invest. 71: 1544-1553, 1983.
4. Brockenbrough, J. S., G. C. Weir, and S. Bonner-Weir. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 37: 232-236, 1988.
5. Butler, P. C., J. Chou, W. B. Carter, Y. N. Wang, B. H. Bu, D. Chang, J. K. Chang, and R. Rizza. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
6. Chen, C., B. Thorens, S. Bonner-Weir, G. C. Weir, and J. L. Leahy. Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter. Diabetes 41: 1320-1327, 1992.
7. Cooper, G. J., A. C. Willis, A. Clark, R. C. Turner, R. B. Sim, and K. B. Reid. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632, 1987.
8. Dunbar, J. C., and P. P. Foà. An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal rats. Diabetologia 10: 27-35, 1974.
9. Féry, F., and E. O. Balasse. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes 43: 1418-1425, 1994.
10. Gedulin, B., G. J. Cooper, and A. A. Young. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem. Biophys. Res. Commun. 180: 782-789, 1991.
11. Gold, G., and G. M. Grodsky. Kinetic aspects of compartmental storage and secretion of insulin and zinc. Experientia 40: 1105-1114, 1984.
12. Greenwood, R. H., R. F. Mahler, and C. N. Hales. Improvement in insulin secretion in diabetes after diazoxide. Lancet 1: 444-447, 1976.
13. Grill, V., M. Westberg, and C.-G. Östenson. B-cell insensitivity in a rat model of non-insulin-dependent diabetes: evidence for a rapidly reversible effect of previous hyperglycemia. J. Clin. Invest. 80: 664-669, 1987.
14. Hosokawa, Y. A., H. Hosokawa, C. Chen, and J. L. Leahy. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats: study using GLP-1 (7-37). J. Clin. Invest. 97: 180-186, 1996.
15. Hosokawa, Y. A., and J. L. Leahy. Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats. Diabetes 46: 808-813, 1997.
16. Inoue, K., A. Hisatomi, F. Umeda, and H. Nawata. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment. Diabetes 41: 723-727, 1992.
17. Kautzky-Willer, A., K. Thomaseth, B. Ludvik, P. Nowotny, D. Rabensteiner, W. Waldhäusl, G. Pacini, and R. Prager. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46: 607-614, 1997.
18. Laedtke, T., O. Schmitz, N. Porksen, J. Veldhuis, and P. Butler. Mechanism of impaired pulsatile insulin secretion in NIDDM? (Abstract) Diabetes 45, Suppl. 2: 40A, 1996.
19. Leahy, J. L. Natural history of B-cell dysfunction in NIDDM. Diabetes Care 13: 992-1010, 1990.
20. Leahy, J. L. β-Cell dysfunction with chronic hyperglycemia: the "overworked β-cell" hypothesis. Diabetes Rev. 4: 298-319, 1996.
21. Leahy, J. L., L. M. Bumbalo, and C. Chen. Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43: 173-179, 1994.
22. Leahy, J. L., and G. C. Weir. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia. Diabetes 37: 217-222, 1988.
23. Ling, Z., R. Kiekins, T. Mahler, F. C. Schuit, M. Pipeleers-Marichal, A. Sener, G. Klöppel, W. J. Malaisse, and D. G. Pipeleers. Effects of chronically elevated glucose levels on the functional properties of rat pancreatic β-cells. Diabetes 45: 1774-1782, 1996.
24. Montaña, E., S. Bonner-Weir, and G. C. Weir. Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass. J. Clin. Invest. 93: 1577-1582, 1994.
25. Mulder, H., B. Ahrén, M. Stridsberg, and F. Sundler. Nonparallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment. Diabetologia 38: 395-402, 1995.
26. Mulder, H., B. Ahrén, and F. Sundler. Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents. Mol. Cell. Endocrinol. 114: 101-109, 1995.
27. Mulder, H., B. Ahrén, and F. Sundler. Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia 39: 649-657, 1996.
28. N'Guyen, J.-M., C. Magnan, M.-C. Laury, C. Thibault, J. Leveteau, M. Gilbert, L. Pénicaud, and A. Ktorza. Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic β cell in rats. J. Clin. Invest. 94: 1456-1462, 1994.
29. O'Connor, M. D. L., H. Landahl, and G. M. Grodsky. Comparison of storage- and signal-limited models of pancreatic insulin secretion. Am. J. Physiol. 238 (Regulatory Integrative Comp. Physiol. 7): R378-R389, 1980.
30. Pittner, R. A., K. Albrandt, K. Beaumont, L. S. L. Gaeta, L. E. Koda, C. X. Moore, J. Rittenhouse, and T. J. Rink. Molecular physiology of amylin. J. Cell. Biochem. 55S: 19-28, 1994.
31. Schatz, H., C. Nierle, and E. F. Pfeiffer. (Pro-)insulin biosynthesis and release of newly synthesized (pro-)insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas. Eur. J. Clin. Invest. 5: 477-485, 1975.
32. Schatz, H., D. Steinle, and E. F. Pfeiffer. Long-term actions of sulfonylureas on (pro-)insulin biosynthesis and secretion. 1. Lack of evidence for a compensatory increase in (pro)insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro. Horm. Met. Res. 9: 457-465, 1977.
33. Strubbe, J. H. Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in the rat. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R615-R618, 1992.
34. Ward, W. K., D. C. Bolgiano, B. McKnight, J. B. Halter, and D. Porte, Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 74: 1318-1328, 1984.
35. Weir, G. C., S. D. Knowlton, and D. B. Martin. Glucagon secretion from the perfused rat pancreas: studies with glucose and catecholamines. J. Clin. Invest. 54: 1403-1412, 1974.
36. Young, A. A., W. Vine, B. R. Gedulin, R. Pittner, S. Janes, L. S. L. Gaeta, A. Percy, C. X. Moore, J. E. Coda, T. J. Rink, and K. Beaumont. Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Devel. Res. 37: 231-248, 1996.
37. Zangen, D. H., S. Bonner-Weir, C. H. Lee, J. B. Latimer, C. P. Miller, J. F. Habener, and G. C. Weir. Reduced insulin, GLUT2, and IDX-1 in β-cells after partial pancreatectomy. Diabetes 46: 258-264, 1996.
38. Zawalich, W. S., K. C. Zawalich, and H. Rasmussen. Interactions between cholinergic agonists and enteric factors in the regulation of insulin secretion from isolated perifused rat islets. Acta Endocrinol. 120: 702-707, 1989.